Diadema Partners »

Abbvie shares owned by Diadema Partners

Quarter-by-quarter ownership of Abbvie (ABBV) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Abbvie

Tip: Access up to 7 years of quarterly data

All positions including Abbvie held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abbvie by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.2M 24k 217.49

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Abbvie

BlackRock
Vanguard Capital Management
State Street Corporation
Vanguard Portfolio Management
Geode Capital Management
Morgan Stanley
Capital Research Global Investors
Bank of America Corporation
FMR
Northern Trust
Goldman Sachs Group
Capital World Investors
UBS Group
Franklin Resources
Capital Research and Management Company - Division 3

View all funds holding Abbvie